📋 Neoleukin Therapeutics, Inc. (NLTX) - Other Event
Filing Date: 2022-07-27
Accepted: 2022-07-27 08:40:06
Event Type: Other Event
Event Details:
Neoleukin Therapeutics Inc (was merged wih Neurogene (NASDAQ: NGNE) on 19/12/23) (NLTX) Provides Business Update
Neoleukin Therapeutics Inc (was merged wih Neurogene (NASDAQ: NGNE) on 19/12/23) (NLTX) issued a business update covering recent developments.
🔍 Detailed Event Analysis:
AI Summary: 1 2 ex-991xpressreleaseofneole. Details of the event are as follows:Date: Tuesday, August 9, 2022Time: 1:30 p. Neoleukin uses sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins.
Key Elements Identified:
Drugs/Compounds: available
Diseases/Conditions: cancer
Organizations: de novo, Neoleukin Therapeutics, Inc.
💼 Business Developments:
No business developments data available.
Structured Data:
Company Name: Neoleukin Therapeutics Inc (was merged wih Neurogene (NASDAQ: NGNE) on 19/12/23)
📋 Neoleukin Therapeutics, Inc. (NLTX) - Other Event
Filing Date: 2022-07-27
Accepted: 2022-07-27 08:40:06
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: 1 2 ex-991xpressreleaseofneole. Details of the event are as follows:Date: Tuesday, August 9, 2022Time: 1:30 p. Neoleukin uses sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins.
Key Elements Identified:
💼 Business Developments:
No business developments data available.
Structured Data: